Seaport Therapeutics Ownership | Who Owns Seaport Therapeutics?
Seaport Therapeutics Ownership Summary
Seaport Therapeutics is owned by 70.07% institutional investors, 35.06% insiders. Arch venture management is the largest institutional shareholder, holding 11.76% of SPTX shares. T. Rowe Price Health Sciences is the top mutual fund, with 2.14% of its assets in Seaport Therapeutics shares.
SPTX Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Seaport Therapeutics | 70.07% | 35.06% | -5.12% |
| Sector | Healthcare Stocks | 247.07% | 12.15% | -159.22% |
| Industry | Biotech Stocks | 385.89% | 11.79% | -297.68% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Arch venture management | 6.29M | 11.76% | $136.60M |
| General atlantic | 6.10M | 11.40% | $132.53M |
| Sofinnova investments | 3.56M | 6.66% | $77.43M |
| Goldman sachs group | 2.18M | 4.07% | $47.32M |
| Trv gp vi | 2.06M | 3.85% | $44.77M |
| Canada pension plan investment board | 1.98M | 3.69% | $42.91M |
| Fmr | 1.84M | 3.43% | $37.07M |
| Foresite capital management vi | 1.78M | 3.32% | $38.65M |
| Jpmorgan chase | 1.60M | 2.98% | $29.84M |
| Price t rowe associates inc /md/ | 1.31M | 2.44% | $28.42M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Trv gp vi | 2.06M | 19.27% | $44.77M |
| Arch venture management | 6.29M | 12.42% | $136.60M |
| Foresite capital management vi | 1.78M | 6.01% | $38.65M |
| General atlantic | 6.10M | 4.56% | $132.53M |
| Sofinnova investments | 3.56M | 4.00% | $77.43M |
| Siren | 1.10M | 0.52% | $22.09M |
| Bellevue group | 1.10M | 0.50% | $23.89M |
| Pier capital | 169.99K | 0.49% | $3.69M |
| Braidwell lp | 500.00K | 0.40% | $10.86M |
| Advisorshares investments | 94.00K | 0.24% | $1.90M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Arch venture management | 6.29M | 12.42% | 6.29M |
| General atlantic | 6.10M | 4.56% | 6.10M |
| Sofinnova investments | 3.56M | 4.00% | 3.56M |
| Goldman sachs group | 2.18M | 0.00% | 2.18M |
| Trv gp vi | 2.06M | 19.27% | 2.06M |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ubs group | 12.46K | - | -266.72K |
| Jpmorgan chase | 1.60M | 0.00% | -219.24K |
| Abrdn | 267.68K | 0.05% | -42.68K |
| Principal financial group | 377.39K | 0.00% | -37.28K |
| Squarepoint ops | - | - | -24.75K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Arch venture management | 6.29M | 12.42% | 6.29M | $136.60M |
| General atlantic | 6.10M | 4.56% | 6.10M | $132.53M |
| Sofinnova investments | 3.56M | 4.00% | 3.56M | $77.43M |
| Goldman sachs group | 2.18M | 0.00% | 2.18M | $47.32M |
| Trv gp vi | 2.06M | 19.27% | 2.06M | $44.77M |
Sold Out
| Holder | Change |
|---|---|
| Squarepoint ops | -24.75K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | 55 | - | 37,506,589 | - | 70 | - | 55 | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| T. Rowe Price Health Sciences | 1.14M | 2.14% | - |
| JPMorgan Small Cap Growth A | 734.13K | 1.37% | -93.85K |
| Jennison Health Sciences Equity | 438.75K | 0.82% | 438.75K |
| PGIM Jennison Health Sciences Z | 438.75K | 0.82% | - |
| Vanguard Morn Total Stk Mkt Idx Investor | 426.37K | 0.80% | 372.00K |
| Vanguard MStar Total Stk Mkt Idx Invest | 426.37K | 0.80% | - |
| Fidelity Growth Company Fund | 424.19K | 0.79% | 73.50K |
| Fidelity Growth Compy Commingled Pl S | 356.20K | 0.67% | 60.40K |
| iShares Russell 2000 ETF | 345.56K | 0.65% | - |
| Fidelity Blue Chip Growth | 235.90K | 0.44% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Nov 03, 2026 | Torres Denice | - | Buy | $99.33K |
| Jun 22, 2026 | HOMBACH ROBERT J. | - | Buy | $235.77K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q4 | 1 | - |
| 2026 Q2 | 1 | - |
SPTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools